The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
Feasibility of a Physical Activity Program in Patients With Metastatic Breast Cancer and Overweight: a Randomized Controlled Trial
1 other identifier
interventional
21
1 country
1
Brief Summary
The goal of this clinical trial is to test a physical activity program in patients with metastatic breast cancer and overweight receiving endocrine-based treatment. The aim of the study is to assess the feasibility of a 12-week physical activity program in this patient group in terms of adherence, recruitment rate, retention and acceptability. Potential effects on metabolic health, body composition, physical performance, obesity-related biomarkers and patient-related outcomes are explored. The hypothesis is that improving metabolic health and health-related quality of life through physical activity can optimize cancer care. Participants will randomized 2:1 to either a physical activity program or care as usual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 19, 2024
CompletedFirst Submitted
Initial submission to the registry
March 6, 2024
CompletedFirst Posted
Study publicly available on registry
April 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2025
CompletedApril 27, 2025
April 1, 2025
1.2 years
March 6, 2024
April 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment rate
Recruitment rate calculated by the amount of included partcipants of those eligible
1 year
Adherence to the training program
Adherence to the training program assessed by the mean attendance rate
1 year
Retention
Retention rate to the study assessed by the proportion of participants in each study arm that completes the study period
1,5 years
Adherence to other study procedures
Adherence to other study procedures assessed by the proportion of completed questionnaires and blood samples at the specified time-points
1,5 years
Acceptability
Acceptability of the study intervention assessed by the proportion of participants in the intervention arm that anwers "yes" to the question: "Would you recommend others to participate in the physical activity program?"
1 year
Other Outcomes (17)
Health-related quality of life as assessed by EORTC-QLQ-30
Until the end of study
Metabolic score
Until the end of study
Self-efficacy of cancer coping as assessed by CBI-12
Until end of study
- +14 more other outcomes
Study Arms (2)
Intervention Arm
EXPERIMENTAL14 participants
Observational Arm
NO INTERVENTION7 participants
Interventions
12-week physical activity program with training 3 times a week. The training consists of high-intensity training such as weight-lifting and cardiovascular training, and low-intensity training such as relaxation and stretching.
Eligibility Criteria
You may qualify if:
- Diagnosed metastatic breast cancer
- BMI ≥ 25
- Receive first-line endocrine-based therapy
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1
You may not qualify if:
- Psychological, familial, sociological, or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; these conditions will be discussed with the patient before registration in the trial.
- Physical health condition that either is unsafe for participation or prevents the patient from participating adequately in the physical activity program.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- Danish Cancer Societycollaborator
Study Sites (1)
Department of Oncology, Aarhus University Hospital
Aarhus N, Central Jutland, 8200, Denmark
Related Publications (1)
Wissing M, Skovlund P, Drysdale S, Amidi A, Zachariae R, Laurberg T, Borgquist S. Feasibility of an exercise program in endocrine-treated metastatic breast cancer patients with overweight: protocol for the FEMA study. Pilot Feasibility Stud. 2025 Apr 2;11(1):36. doi: 10.1186/s40814-025-01621-9.
PMID: 40176194DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Signe SB Borgquist, MD, PhD
Aarhus University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair Professor, Senior Consultant, PhD
Study Record Dates
First Submitted
March 6, 2024
First Posted
April 3, 2024
Study Start
February 19, 2024
Primary Completion
April 24, 2025
Study Completion
April 24, 2025
Last Updated
April 27, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share